Markets:

Overview

News

Currencies

International

Treasuries

Moderna, Inc. - Common Stock (NQ:MRNA)

24.77 -0.19 (-0.76%)

Streaming Delayed Price Updated: 4:00 PM EST, Nov 14, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Moderna, Inc. - Common Stock

< Previous 1 2

...

27 28 29 30 31 32 33 34 35

...

99 100 Next >

Investor That Backed Moderna Raises $3.6B For AI-driven Biotech Ventures ↗

July 10, 2024

The funds are intended to launch a series of new biotech companies that will harness the power of generative artificial intelligence for drug discovery.

Via Benzinga

Topics Artificial Intelligence

Moderna to Report Second Quarter 2024 Financial Results on Thursday, August 1, 2024

July 10, 2024

Via ACCESSWIRE

Moderna To Collaborate With Mitsubishi On Respiratory Vaccine Promotion In Japan ↗

July 09, 2024

Moderna and Mitsubishi signed a joint agreement regarding the co-promotion of Moderna's respiratory vaccine portfolio in Japan.

Via Benzinga

Moderna And Mitsubishi Tanabe Pharma Corporation Enter Joint Agreement to Promote Moderna’s mRNA Respiratory Vaccine Portfolio in Japan, Including COVID-19 Vaccines

July 08, 2024

Via ACCESSWIRE

3 Healthcare Stocks to Sell in July Before They Crash & Burn ↗

July 08, 2024

Many healthcare names are attractive. But drugstore chains and some drug makers have poor outlooks. Here are three healthcare stocks to sell.

Via InvestorPlace

Unpacking the Latest Options Trading Trends in Moderna ↗

July 08, 2024

Via Benzinga

Unpacking the Latest Options Trading Trends in Moderna ↗

July 05, 2024

Via Benzinga

Here's How Much $1000 Invested In Moderna 5 Years Ago Would Be Worth Today ↗

July 04, 2024

Via Benzinga

The 3 Best Gene Editing Stocks to Buy in July 2024 ↗

July 08, 2024

Gene editing is revolutionizing medicine, creating substantial opportunities for some of the best gene editing stocks.

Via InvestorPlace

3 Biotech Stocks to Sell in July Before They Crash & Burn ↗

July 05, 2024

While biotech stocks have potential to provide high returns, they are often overly dependent on drug approvals. Sell these before its too late

Via InvestorPlace

3 Biotech Stocks Turning DNA Dreams Into Dollars ↗

July 05, 2024

Investors should consider buying into one of the future avenues of medicine by investing in these three BNA biotech stocks.

Via InvestorPlace

AI Has 'The Hallmarks Of An Inflating Bubble,' Warns Veteran Wall Street Investor ↗

July 04, 2024

Word to the wise: Ed Yardeni, in a July 4 note, warns his clients: "Too much capital can end even the best of parties."

Via Benzinga

Topics Artificial Intelligence

What's Going On With Moderna Stock Wednesday ↗

July 03, 2024

Moderna announced a $176 million award for the development of an mRNA-based Influenza vaccine.

Via Benzinga

What's Going On With Moderna Stock Friday? ↗

June 28, 2024

Moderna's RSV vaccine, mRNA-1345, is designed to protect adults aged 60 and older from respiratory disease caused by the RSV infection.

Via Benzinga

In-Depth Examination Of 10 Analyst Recommendations For Moderna ↗

June 27, 2024

Via Benzinga

mRNA Technology Promises To Make A Long-Time Coming Turning Point In Cancer Treatment ↗

July 02, 2024

The medical and pharmaceutical community continues to embrace emerging technologies, beginning with mRNA that rose to fame during the COVID-19 pandemic. The beauty of mRNA technology is that it opens...

Via Benzinga

London High Court Ruling Fuels Pfizer And Moderna Legal Dispute Over COVID-19 Vaccine Patents ↗

July 02, 2024

Pfizer and Moderna continue their legal battle over COVID-19 vaccine patents following a mixed ruling by London's High Court, with potential appeals on the horizon and significant financial stakes...

Via Benzinga

Topics Intellectual Property

Biotech Stock Breakout: IBB Eyes Resistance with Amgen and Vertex

July 02, 2024

The biotech sector (IBB) is trading just 3% away from its 52-week high and a significant resistance level, suggesting a potential breakout.

Via MarketBeat

Topics ETFs

Amid Rapidly Rising Bird Flu Cases, Moderna Lands $176M Worth US Government Contract For Vaccine ↗

July 02, 2024

The funds will be utilized to finalize the late-stage development and testing of a pre-pandemic mRNA-based vaccine against H5N1 avian influenza.

Via Benzinga

Moderna Receives Project Award through BARDA's Rapid Response Partnership Vehicle Consortium to Accelerate Development of mRNA-based Pandemic Influenza Vaccine

July 02, 2024

Via ACCESSWIRE

Surprise! 3 Stocks That Are Outperforming Nvidia in 2024. ↗

July 01, 2024

There are more marketplace opportunities than just AI which is why these stocks that are outperforming Nvidia have done so well.

Via InvestorPlace

Topics Artificial Intelligence

Moderna And Walgreens Boots Alliance Were Among The 10 Biggest Large Cap Losers Last Week (June 23 - June 29): Are These In Your Portfolio? ↗

June 30, 2024

10 worst performing large-cap stocks last week: Walgreens, Floor & Decor, Moderna, Birkenstock, BeiGene, Pool Corp, JD.com, Ecopetrol, International Paper, Micron.

Via Benzinga

Treasure Hunt: 3 Biotech Stocks Wall Street Hasn’t Discovered Yet ↗

June 28, 2024

Undiscovered biotech stocks can be risky but rewarding, especially when it involves mid-cap stocks with promise and no profit.

Via InvestorPlace

EMA Committee For Medicinal Products For Human Use Adopts Positive Opinion Recommending Marketing Authorization Of Moderna’s RSV Vaccine, mRESVIA(R)

June 28, 2024

Via ACCESSWIRE

Silver Prices Fell To A 6-Week Low ↗

June 27, 2024

Silver prices held below $29 an ounce, near a six-week low, and were pressured by a strong dollar and Treasury bond yields after hawkish remarks from a Federal Reserve official.

Via Talk Markets

Topics Bonds Economy

CDC Advisor Panel Recommends RSV Shots In US For People Above 75 Years, Analyst Says Decision Negative For GSK ↗

June 27, 2024

The CDC's ACIP recommends RSV vaccines for adults 75+, and for those 60-74 with chronic conditions. GSK's Arexvy is approved for adults 50-59 at risk. A decision on adults 50-59 is pending further...

Via Benzinga

2 Stocks Down More Than 30% to Buy Right Now ↗

June 27, 2024

These stocks have suffered as the demand for their biggest product -- the coronavirus vaccine -- waned.

Via The Motley Fool

10 Health Care Stocks Whale Activity In Today's Session ↗

June 26, 2024

Via Benzinga

Dow Nearly 100 Points Lower Amid Slumping Home Sales ↗

June 26, 2024

Via Talk Markets

Topics Stocks

Why Is Moderna Stock Trading Lower On Wednesday? ↗

June 26, 2024

The CDC's Advisory Committee on Immunization Practices is set to discuss recommendations for RSV, influenza, and COVID-19 vaccines. Moderna's data shows vaccine efficacy drops to 50% after 18 months in...

Via Benzinga

< Previous 1 2

...

27 28 29 30 31 32 33 34 35

...

99 100 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.